Owners, management and financials
CVR: 27206506
Secondary names: Medivit ApS, Gallivit ApS
Previous names: ApS KBIL 17 NR. 1578, GALLIVIT ApS
DKK 8,519,379
Gross profit
Net result: DKK 4,924,772
Eskro Holding ApS (50-66,65%), Kr. Krogh Holding ApS (50-66,65%)
CVR · view owners
Kristian Krogh, Eskil Krogh
CVR · view management
Active
Founded 16 June 2003
CVR · view overview
2 employees
CVR · 2018
Owner registered: Eskro Holding ApS
CVR · 20/12/2024
View the full event history
Pharmovital ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2003. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named GALLIVIT ApS and ApS KBIL 17 NR. 1578. The management consists of Kristian Krogh and Eskil Krogh. The company is owned by Eskro Holding ApS and Kr. Krogh Holding ApS. The company has 2 employees (2018). In 2026, the company reported a gross profit of DKK 8,519,379 and a net result of DKK 4,924,772 compared with DKK 586,153 the year before. Equity in the 2026 report amounted to DKK 8,743,173.
Source: annual report 2026, Danish Business Authority
Pharmovital ApS demonstrates a strong upward trajectory in profitability, with gross profit increasing from 2.5 million DKK in 2022 to 8.5 million DKK in 2026, and profit rising from 718,535 DKK to 4.9 million DKK over the same period. The company's equity has also seen significant growth, reaching 8.7 million DKK in 2026, indicating a solid financial foundation. However, the absence of revenue figures raises concerns about transparency and overall sales performance. With a focus on wholesale food distribution, Pharmovital appears well-positioned in its industry, benefiting from improving margins and profitability.
AI-generated summary · Generated 12/09/2026
Selskabets formål er at drive produktion, handel og al virksomhed som efter direktionens skøn er beslægtet hermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202601/07/2025 – 30/06/2026 | 8.5 mio. | 4.9 mio. | 19.1 mio. | 8.7 mio. | 2 | |
| 202501/07/2024 – 30/06/2025 | 2.4 mio. | 586 t. | 7.8 mio. | 3.8 mio. | 2 | |
| 202401/07/2023 – 30/06/2024 | 3 mio. | 1.2 mio. | 6.2 mio. | 3.5 mio. | 3 | |
| 202301/07/2022 – 30/06/2023 | 2.9 mio. | 1 mio. | 6.4 mio. | 2.6 mio. | 3 | |
| 202201/07/2021 – 30/06/2022 | 2.5 mio. | 719 t. | 6.5 mio. | 2.3 mio. | 3 | |
| 202101/07/2020 – 30/06/2021 | 1.1 mio. | -772 t. | 5.4 mio. | 1.9 mio. | 3 | |
| 202001/07/2019 – 30/06/2020 | 1.8 mio. | 251 t. | 4.3 mio. | 1.7 mio. | 2 | |
| 201901/07/2018 – 30/06/2019 | 2.3 mio. | 807 t. | 4.4 mio. | 1.6 mio. | 2 | |
| 201801/07/2017 – 30/06/2018 | 1.2 mio. | -353 t. | 3 mio. | 828 t. | 2 | |
| 201701/07/2016 – 30/06/2017 | 1.8 mio. | 53 t. | 3.1 mio. | 1.2 mio. | - | |
| 201601/07/2015 – 30/06/2016 | 1.9 mio. | 310 t. | 3 mio. | 1.1 mio. | - | |
| 201501/07/2014 – 30/06/2015 | 1.8 mio. | 481 t. | 3.4 mio. | 818 t. | - | |
| 201401/07/2013 – 30/06/2014 | 1.7 mio. | -942 t. | 2.7 mio. | 336 t. | 2 | |
| 201301/07/2012 – 30/06/2013 | 1.5 mio. | 481 t. | 3.2 mio. | 1.3 mio. | - |
Compared to 333 companies in Engroshandel med andre fødevarer
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Pharmovital ApS is 27206506.
Pharmovital ApS is owned by Eskro Holding ApS and Kr. Krogh Holding ApS.
The management of Pharmovital ApS consists of Kristian Krogh and Eskil Krogh.
In 2026, Pharmovital ApS reported a gross profit of DKK 8,519,379.
Pharmovital ApS had 2 employees in 2018 according to the Danish CVR register.
Pharmovital ApS was founded on 16 June 2003.
Claim this page to add your logo and social links. Free to get started.
Pharmovital ApS has published its annual report for 2026. Gross profit came to DKK 8,519,379, and the net result was DKK 4,924,772.
Contact info changed: new phone: 25328499, new email: [email protected] (March 23, 2026).
Pharmovital ApS has published its annual report for 2025. Gross profit came to DKK 2,379,629, and the net result was DKK 586,153.
As of December 20, 2024, Eskro Holding ApS is registered as an owner of Pharmovital ApS with an ownership share of 50%.
As of December 20, 2024, Kr. Krogh Holding ApS is registered as an owner of Pharmovital ApS with an ownership share of 50%.
Pharmovital ApS has published its annual report for 2024. Gross profit came to DKK 3,018,197, and the net result was DKK 1,153,281.
Pharmovital ApS has published its annual report for 2023. Gross profit came to DKK 2,909,130, and the net result was DKK 1,029,654.
Pharmovital ApS has published its annual report for 2022. Gross profit came to DKK 2,524,145, and the net result was DKK 718,535.
Pharmovital ApS has published its annual report for 2021. Gross profit came to DKK 1,073,041, and the net result was DKK -772,171.
Pharmovital ApS has published its annual report for 2020. Gross profit came to DKK 1,816,032, and the net result was DKK 250,693.
Pharmovital ApS has published its annual report for 2019. Gross profit came to DKK 2,329,230, and the net result was DKK 807,052.
On November 20, 2019, the company changed its name from GALLIVIT ApS to Pharmovital ApS.
Pharmovital ApS has published its annual report for 2018. Gross profit came to DKK 1,183,736, and the net result was DKK -353,291.
Pharmovital ApS has published its annual report for 2017. Gross profit came to DKK 1,799,114, and the net result was DKK 53,052.
Pharmovital ApS has published its annual report for 2016. Gross profit came to DKK 1,850,436, and the net result was DKK 310,325.
Pharmovital ApS has published its annual report for 2015. Gross profit came to DKK 1,808,633, and the net result was DKK 481,325.
As of February 28, 2015, PIASTER REVISORERNE, STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of Pharmovital ApS.
As of February 28, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Pharmovital ApS.
Pharmovital ApS has published its annual report for 2014. Gross profit came to DKK 1,738,991, and the net result was DKK -942,091.
Pharmovital ApS has published its annual report for 2013. Gross profit came to DKK 1,536,175, and the net result was DKK 481,077.
As of August 23, 2013, A/S PSE 17 NR. 1260 has stepped down as auditor of Pharmovital ApS.
As of January 23, 2012, EY Godkendt Revisionspartnerselskab has been appointed auditor of Pharmovital ApS.
As of April 15, 2006, Steffen Møller has left the board of directors of Pharmovital ApS.
As of April 15, 2006, Kristian Krogh has left the board of directors of Pharmovital ApS.
As of April 15, 2006, Eskil Krogh has left the board of directors of Pharmovital ApS.
As of April 15, 2006, Kristian Krogh is registered as adm. dir. of Pharmovital ApS.
As of October 1, 2004, Hans Ole Svendsen has left the board of directors of Pharmovital ApS.
As of July 10, 2003, A/S PSE 17 NR. 1260 has been appointed auditor of Pharmovital ApS.
As of July 10, 2003, JUT NR. 2180 A/S has stepped down as auditor of Pharmovital ApS.
As of July 10, 2003, Hans Ole Svendsen has joined the board of directors of Pharmovital ApS.
As of July 10, 2003, Steffen Møller has joined the board of directors of Pharmovital ApS.
As of July 10, 2003, Kristian Krogh has joined the board of directors of Pharmovital ApS.
As of July 10, 2003, Eskil Krogh has joined the board of directors of Pharmovital ApS.
As of July 10, 2003, Kim Madsen has left the board of directors of Pharmovital ApS.
As of July 10, 2003, Eskil Krogh is registered as director of Pharmovital ApS.
As of July 10, 2003, Annemette Heller has stepped down as adm. dir. of Pharmovital ApS.
On July 10, 2003, the company changed its name from ApS KBIL 17 NR. 1578 to GALLIVIT ApS.
As of June 16, 2003, JUT NR. 2180 A/S has been appointed auditor of Pharmovital ApS.
As of June 16, 2003, Kim Madsen has joined the board of directors of Pharmovital ApS.
As of June 16, 2003, Annemette Heller is registered as adm. dir. of Pharmovital ApS.
Pharmovital ApS was founded on June 16, 2003.
2 news items and press releases
Vægttabsbølgen har for alvor ramt Danmark, hvor virksomheden bag det populære produkt Formoline L112 nu står med et tomt lager. Pharmovital fremrykker derfor produktionen og varsler, at knap 400.000 nye pakker er på vej.
Politisk debat og en kommende overvægtskonference sætter vægttab på dagsordenen. Vi taler dog for lidt om, hvordan danskerne får hjælp til at fastholde vægten, mener Pharmovital.
Sources: Via Ritzau and Danish news media. Links open at the source.
Companies in the same industry and area
CVR 10010527
CVR 11921019
CVR 36229349
CVR 41686669
CVR 30260430
